scholarly journals Predictors of Participation in Prostate Cancer Screening among Older Men in Jordan

2015 ◽  
Vol 16 (13) ◽  
pp. 5377-5383 ◽  
Author(s):  
Mohammad H Abuadas ◽  
Wasileh Petro-Nustas ◽  
Zainab F. Albikawi
2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
Belinda F. Morrison ◽  
William Aiken ◽  
Richard Mayhew ◽  
Yulit Gordon ◽  
Marvin Reid

Prostate cancer is highly prevalent in Jamaica and is the leading cause of cancer-related deaths. Our aim was to evaluate the patterns of screening in the largest organized screening clinic in Jamaica at the Jamaica Cancer Society. A retrospective analysis of all men presenting for screening at the Jamaica Cancer Society from 1995 to 2005 was done. All patients had digital rectal examinations (DRE) and prostate specific antigen (PSA) tests done. Results of prostate biopsies were noted. 1117 men of mean age 59.9 ± 8.2 years presented for screening. The median documented PSA was 1.6 ng/mL (maximum of 5170 ng/mL). Most patients presented for only 1 screen. There was a gradual reduction in the mean age of presentation for screening over the period. Prostate biopsies were requested on 11% of screening visits; however, only 59% of these were done. 5.6% of all persons screened were found to have cancer. Of the cancers diagnosed, Gleason 6 adenocarcinoma was the commonest grade and median PSA was 8.9 ng/mL (range 1.5–1059 ng/mL). Older men tend to screen for prostate cancer in Jamaica. However, compliance with regular maintenance visits and requests for confirmatory biopsies are poor. Screening needs intervention in the Jamaican population.


2011 ◽  
Vol 29 (13) ◽  
pp. 1736-1743 ◽  
Author(s):  
Michael W. Drazer ◽  
Dezheng Huo ◽  
Mara A. Schonberg ◽  
Aria Razmaria ◽  
Scott E. Eggener

Purpose For patients who elect to have prostate cancer screening, the optimal time to discontinue screening is unknown. Our objective was to describe rates and predictors of prostate-specific antigen (PSA) screening among older men in the United States. Methods Data were extracted from the population-based 2000 and 2005 National Health Interview Survey (NHIS). PSA screening was defined as a PSA test as part of a routine exam within the past year. Demographic, socioeconomic, and functional characteristics were collected, and a validated 5-year estimated life expectancy was calculated. Age-specific rates of PSA screening were determined, and sampling weight-adjusted multivariate regressions were fitted to determine predictors of screening among men age 70 years or older. Results The PSA screening rate was 24.0% in men age 50 to 54 years, and it increased steadily with age until a peak of 45.5% among age 70 to 74 years. Screening rates then gradually declined by age, and 24.6% of men age 85 years or older reported being screened. Among men age 70 years or older, screening rates varied by estimated 5-year life expectancy: rates were 47.3% in men with high life expectancies (≤ 15% probability of 5-year mortality), 39.2% in men with intermediate life expectancies (16% to 48% probability), and 30.7% in men with low life expectancies (> 48% probability; P < .001). In multivariate analysis, estimated life expectancy and age remained independently associated with PSA screening (P < .001 for each). Conclusion Rates of PSA screening in the United States are associated with age and estimated life expectancy, but excessive PSA screening in elderly men with limited life expectancies remains a significant problem. The merits and limitations of PSA should be discussed with all patients considering prostate cancer screening.


2019 ◽  
Vol 67 (9) ◽  
pp. 1922-1927 ◽  
Author(s):  
Thomas R. Radomski ◽  
Yan Huang ◽  
Seo Young Park ◽  
Florentina E. Sileanu ◽  
Carolyn T. Thorpe ◽  
...  

2016 ◽  
Vol 11 (1) ◽  
pp. 31-41 ◽  
Author(s):  
Mohammad H. Abuadas ◽  
Wasileh Petro-Nustas ◽  
Zainab F. Albikawi ◽  
Mohammad Mari

2007 ◽  
Vol 5 (7) ◽  
pp. 703-708 ◽  
Author(s):  
Douglass B. Clayton ◽  
Donald A. Urban

The prediction of life expectancy in prostate cancer screening and treatment is a controversial topic that evokes various opinions regarding its validity. The authors believe incorporating life expectancy prediction into the treatment algorithms for prostate cancer is important. Using a combination of clinical judgment and specific predictive tools, physicians can estimate the life expectancy of patients with prostate cancer. These estimates can then be used to help guide treatment discussion. Estimating life expectancy benefits older men in whom decisions regarding the best form of treatment may be difficult.


2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S641-S641
Author(s):  
Tamara J Cadet ◽  
Shanna L Burke ◽  
Jamie Mitchel ◽  
Kyaien Conner ◽  
Frances Nedjat-Haiem

Abstract Evidence suggests loneliness is associated with poorer health practices and fewer health promoting behaviors, yet may be associated with greater use of the healthcare system. This dichotomy highlights the lack of understanding in the literature about the relationship between the experience of loneliness in early disease detection behaviors, such as prostate cancer screening and appropriate clinical interventions to support older men. Utilizing a series of logistic regression models, this investigation examined the relationship between loneliness and prostate cancer screening in 2008 and 2012 among White, Black, and non-Hispanic men, ages 50-74 years, (n= 4,875 for 2008 and 7.063 for 2012). The data source as the Health and Retirement Study. Findings indicate that White men were less likely to participate in PSA screening in 2008 if they felt left out or isolated. There was a reduced likelihood of screening among Black men who feel as though they have a lot in common with those around them in 2012. Utilizing approaches such as cognitive-behavioral therapy, motivational interviewing, and solution-focused practice, clinical social workers can have shared decision-making conversations to understand this phenomenon. Clinical social workers have unique training in the person-in-environment model that emphasizes the biological, psychological, social, and spiritual factors that influence behaviors such as cancer screening participation, that can help to understand men’s experiences, feelings or needs related to cancer screening participation. Given the lack of focus on men’s, this study provides formative data to test interventions to increase the well-being of older men.


2007 ◽  
Vol 177 (4S) ◽  
pp. 342-342
Author(s):  
Jochen Walz ◽  
Georg Salomon ◽  
Paul Perrotte ◽  
Andrea Gallina ◽  
Georg C. Hutterer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document